Projects per year
Fingerprint
Dive into the research topics where Shridar Ganesan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 8 Finished
-
Mechanisms of the BRCA-network in tumorigenesis and therapeutic response
Bunting, S., Ganesan, S., Shen, Z., Xia, B. & De, S.
4/1/21 → 4/30/22
Project: Research project
-
Impact of mutation burden on cancer growth and the immune landscape
Ganesan, S., Lattime, E. & White, E.
12/1/20 → 11/30/21
Project: Research project
-
Computerized histologic image predictor of cancer outcome
Ganesan, S., Feldman, M. & Madabhushi, A.
7/1/16 → 6/30/20
Project: Research project
-
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
Ganesan, S. & GANESAN, S.
9/1/12 → 6/30/18
Project: Research project
Research output
-
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
Qureshi, S., Chan, N., George, M., Ganesan, S., Toppmeyer, D. & Omene, C., Feb 2022, In: Biomarker Insights. 17Research output: Contribution to journal › Review article › peer-review
Open Access -
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
Palmeri, M., Mehnert, J., Silk, A. W., Jabbour, S. K., Ganesan, S., Popli, P., Riedlinger, G., Stephenson, R., de Meritens, A. B., Leiser, A., Mayer, T., Chan, N., Spencer, K., Girda, E., Malhotra, J., Chan, T., Subbiah, V. & Groisberg, R., Feb 2022, In: ESMO Open. 7, 1, 100336.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Breast cancer among Asian Indian and Pakistani Americans: A surveillance, epidemiology and end results-based study
Satagopan, J. M., Stroup, A., Kinney, A. Y., Dharamdasani, T., Ganesan, S. & Bandera, E. V., Apr 1 2021, In: International Journal of Cancer. 148, 7, p. 1598-1607 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
George, M. A., Qureshi, S., Omene, C., Toppmeyer, D. & Ganesan, S., Jul 12 2021, In: Frontiers in Oncology. 11, 693104.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
Clinical features and multiplatform molecular analysis assist in understanding patient response to anti‐pd‐1/pd‐l1 in renal cell carcinoma
Shiuan, E., Reddy, A., Dudzinski, S. O., Lim, A. R., Sugiura, A., Hongo, R., Young, K., Liu, X. D., Smith, C. C., O’neal, J., Dahlman, K. B., McAlister, R., Chen, B., Ruma, K., Roscoe, N., Bender, J., Ward, J., Kim, J. Y., Vaupel, C., Bordeaux, J. & 11 others, , Mar 2 2021, In: Cancers. 13, 6, 1475.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations